Episode 45: Could biologic injectables change the eczema trajectory?

Could injectable drugs called "biologics" stop eczema by teaching a child's developing immune system to be less reactive? Dr. Amy Paller from Northwestern University Chicago and Dr. Elaine Siegfried from Saint Louis University in Missouri discuss stopping or tapering biologics and what happens to the immune system when we are on them. If you like our podcast, please consider supporting it with a tax deductible donation. Read the transcript.

Research discussed

Clinical remission and off-treatment remission in Infants and Pre-schoolers with moderate to severe atopic dermatitis treated with dupilumab

Clinical remission and therapy-free remission in pediatric patients with moderate-to-severe atopic dermatitis treated with dupilumab

Factors Associated with Remission of Eczema in Children

Persistence of Mild to Moderate Atopic Dermatitis

Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children